Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
13.03
+0.34 (2.68%)
Aug 6, 2026, 10:57 AM EDT - Market open
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $447.64 million as of August 6, 2026. Its market cap has increased by 47.96% in one year.
Market Cap
447.64M
Enterprise Value
252.07M
1-Year Change
47.96%
Ranking
Category
Stock Price
$13.03
ChartMarket Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $447.64M, a decrease of -79.90%. That is a compound annual growth rate of -12.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 447.64M | -1.86% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cabaletta Bio | 436.99M |
| Prothena Corporation | 434.01M |
| Ovid Therapeutics | 429.27M |
| Ocugen | 423.15M |
| Eupraxia Pharmaceuticals | 418.17M |
| Sagimet Biosciences | 411.88M |
| Sutro Biopharma | 405.48M |
| vTv Therapeutics | 404.92M |